PEPTIDE HORMONE SORTING TO THE SECRETORY/STORAGE GRANULE
PEPTIDE HORMONE SORTING TO THE SECRETORY/STORAGE GRANULE
批准号:
2407904
负责人:
PETER ARVAN
金额:
$24.76万
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-09-01 至 1999-01-31
关键词:
Golgi apparatus cathepsin B centrifugation chemical condensation conformation disulfide bond exocytosis granule immunoprecipitation insulin intracellular transport laboratory mouse laboratory rat pancreatic islets peptide hormone biosynthesis polymers posttranslational modifications proinsulin protein structure protein transport secretion secretory protein tissue /cell culture transfection zinc
中文摘要
所有的细胞都会合成分泌蛋白质,但特殊的多肽-
分泌神经内分泌细胞已经发展出一条额外的途径
胞吐作用强烈的颗粒中多肽激素的储存
受特定生理刺激调节的。由于存储颗粒
富含不同于构成和分泌的蛋白质
那些集中在溶酶体中的专业分泌细胞必须
通过过程在内部区分这些不同类别的蛋白质
它们统称为分子分类。中国的脊椎动物门
一般人,尤其是人类,已经将多肽激素的分泌调整为
对抗代谢平衡紊乱的一条主要防线;因此
似乎内分泌细胞中多肽的分子分类,
再加上触发分泌动作的信号,代表着
内分泌动态平衡所基于的精确调节。在一个
一系列人类和动物疾病,包括某些已知的基因
上述类别的分子分类中的突变、变化
分子与各种异常有关,从微小的表型
缺陷是缺乏生命力的有机体。很明显,为了
为了阐明这些分类缺陷的潜在基础,我们必须有
对分拣过程中涉及的分子机制的应用知识
流程。然而,到目前为止,关于
相互矛盾的假说被用来解释多肽激素是如何
通常靶向并集中在分泌颗粒中。简而言之,
这些观点可以分为“条目排序”假设,在这个假设中
蛋白质是在高尔基复合体中预先选择的,以进入存储
颗粒,而不是“按保留排序”假说
含量蛋白质以可溶混合物的形式进入形成颗粒;然后非
储存的蛋白质被选择性地(和非选择性地)移除,而
受调节的分泌蛋白通过缩合成一个
不溶的核心。尽管盛行的科学观点认为
被调节的分泌蛋白被分类以进入存储颗粒
途径,这项赠款申请采取的观点,并打算
进一步检验按保留排序的假说。对…的回顾
背景信息以及几个重要的初步调查结果
为创新实验奠定基础并确立其可行性
其结果可能会导致我们大幅修改我们的思维方式
关于肽荷尔蒙是如何分类和储存的。
英文摘要
All cells secrete proteins constitutively, but specialized polypeptide-
secreting neuroendocrine cells have developed an additional pathway of
storage of peptide hormones in granules whose exocytosis is acutely
regulated by specific physiologic stimuli. Since storage granules are
enriched in proteins different from those secreted constitutively and
those concentrated in lysosomes, professional secretory cells must
internally distinguish these different classes of proteins by processes
that are collectively known as molecular sorting. The vertebrate phylum in
general, and man in particular, have adapted peptide-hormone secretion as
a major line of defense against disturbances in metabolic balance; thus it
appears that the molecular sorting of polypeptides in endocrine cells,
coupled with the signalling that triggers secretagogue action, represent
the precision tuning upon which endocrine homeostasis is based. In an
array of human and animal diseases including certain known genetic
mutations, alterations in molecular sorting of the above classes of
molecules are associated with abnormalities ranging from subtle phenotypic
defects to lack of viability of the organism. It is evident that in order
to elucidate the underlying basis for these sorting defects, we must have
a working knowledge of the molecular mechanisms involved in sorting
processes. However, up to now, there has been great controversy over
conflicting hypotheses created to explain how peptide hormones are
normally targeted and concentrated in secretory granules. In a nutshell,
these views can be divided into a "sorting for entry" hypothesis in which
proteins are pre-selected in the Golgi complex for entry into storage
granules, versus a "sorting by retention" hypothesis in which unsorted
content proteins enter forming granules as a soluble mixture; then non-
stored proteins are selectively (and non-selectively) removed while
regulated secretory proteins are retained by condensation into an
insoluble core. Although the prevailing scientific view has been that
regulated secretory proteins are sorted for entry into the storage granule
pathway, this grant application takes the point of view of, and intends to
further examine, the sorting-by-retention hypothesis. A review of
background information as well as several important preliminary findings
lay the groundwork and establish the feasibility of novel experiments
whose outcome could cause us to revise substantially the way we think
about how peptide hormones are sorted and stored.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Improving Proinsulin Folding to Ameliorate Type II Diabetes
-
批准号:10657292
-
项目类别:
-
资助金额:$80.96万
-
财政年份:2023
-
负责人:PETER ARVAN
-
依托单位:
Endoplasmic Reticulum stress and thyroid cell death
-
批准号:10595662
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2022
-
负责人:PETER ARVAN
-
依托单位:
Endoplasmic Reticulum stress and thyroid cell death
-
批准号:10414536
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2022
-
负责人:PETER ARVAN
-
依托单位:
A Stress-Induced Vicious Cycle In The Development of T1D
-
批准号:10653099
-
项目类别:
-
资助金额:$70.36万
-
财政年份:2020
-
负责人:PETER ARVAN
-
依托单位:
A Stress-Induced Vicious Cycle In The Development of T1D
-
批准号:10262964
-
项目类别:
-
资助金额:$70.36万
-
财政年份:2020
-
负责人:PETER ARVAN
-
依托单位:
A Stress-Induced Vicious Cycle In The Development of T1D
-
批准号:10440524
-
项目类别:
-
资助金额:$70.36万
-
财政年份:2020
-
负责人:PETER ARVAN
-
依托单位:
Interplay Between SERPINB1 and TLR2/TLR4 in Beta Cell Regeneration
-
批准号:10531213
-
项目类别:
-
资助金额:$49.9万
-
财政年份:2018
-
负责人:PETER ARVAN
-
依托单位:
Secretory Pathway Protein Degradation Maintains Insulin Biogenesis + Secretion
-
批准号:10647830
-
项目类别:
-
资助金额:$63.69万
-
财政年份:2016
-
负责人:PETER ARVAN
-
依托单位:
Secretory Pathway Protein Degradation Maintains Insulin Biogenesis + Secretion
-
批准号:10217112
-
项目类别:
-
资助金额:$63.69万
-
财政年份:2016
-
负责人:PETER ARVAN
-
依托单位:
Secretory Pathway Protein Degradation Maintains Insulin Biogenesis + Secretion
-
批准号:10430023
-
项目类别:
-
资助金额:$63.69万
-
财政年份:2016
-
负责人:PETER ARVAN
-
依托单位:
Modifiers of Proinsulin Influence T2D Susceptibility
-
批准号:9351508
-
项目类别:
-
资助金额:$100.88万
-
财政年份:2016
-
负责人:PETER ARVAN
-
依托单位:
Multidisciplinary Training Program in Basic Diabetes Research
-
批准号:10244911
-
项目类别:
-
资助金额:$35.4万
-
财政年份:2014
-
负责人:PETER ARVAN
-
依托单位:
Multidisciplinary Training Program in Basic Diabetes Research
-
批准号:10686283
-
项目类别:
-
资助金额:$36.92万
-
财政年份:2014
-
负责人:PETER ARVAN
-
依托单位:
Multidisciplinary Training Program in Basic Diabetes Research
-
批准号:10596892
-
项目类别:
-
资助金额:$5.51万
-
财政年份:2014
-
负责人:PETER ARVAN
-
依托单位:
Multidisciplinary Training Program in Basic Diabetes Research
-
批准号:10466930
-
项目类别:
-
资助金额:$33.08万
-
财政年份:2014
-
负责人:PETER ARVAN
-
依托单位:
Peptide Hormone Sorting to the Secretory/Storage Granule
-
批准号:8003256
-
项目类别:
-
资助金额:$2.25万
-
财政年份:2009
-
负责人:PETER ARVAN
-
依托单位:
Thyrocyte Protein Transport to the Cell Surface
-
批准号:8003365
-
项目类别:
-
资助金额:$7.74万
-
财政年份:2009
-
负责人:PETER ARVAN
-
依托单位:
How mutations in proinsulin cause diabetes: a protein-misfolding disease
-
批准号:8448597
-
项目类别:
-
资助金额:$44.35万
-
财政年份:2004
-
负责人:PETER ARVAN
-
依托单位:
How mutations in proinsulin cause diabetes: a protein-misfolding disease
-
批准号:8132181
-
项目类别:
-
资助金额:$58.88万
-
财政年份:2004
-
负责人:PETER ARVAN
-
依托单位:
How mutations in proinsulin cause diabetes: a protein-misfolding disease
-
批准号:8640155
-
项目类别:
-
资助金额:$45.85万
-
财政年份:2004
-
负责人:PETER ARVAN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Prdx1通过Cathepsin B激活NLRP3/Caspase-1/GSDMD途径诱导结直肠癌细胞焦亡的作用机制研究
-
批准号:2025JJ60797
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:何影
-
依托单位:
Cathepsin B乳酸化修饰在慢阻肺病合并肌肉减少症中的功能与机制研究
-
批准号:82570063
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:侯刚
-
依托单位:
溶酶体靶向调控和Cathepsin B应激响应的分子构建及其光敏肿瘤靶向治疗研究
-
批准号:82460674
-
项目类别:地区科学基金项目
-
资助金额:32.00万元
-
批准年份:2024
-
负责人:肖奇才
-
依托单位:
HMGB1/TLR4/Cathepsin B途径介导的小胶质细胞焦亡在新生大鼠缺氧缺血脑病中的作用与机制
-
批准号:82371712
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:黑明燕
-
依托单位:
Prdx1通过Cathepsin B激活NLRP3炎症小体诱导肝细胞焦亡加重急性肝衰竭的机制研究
-
批准号:82302454
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:何影
-
依托单位:
鸦胆因D通过Cathepsin B诱导斜纹夜蛾中肠损伤的分子机理
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2021
-
负责人:毛根林
-
依托单位:
Cathepsin B 通过脑类淋巴/淋巴系统影响脑梗死后CSF循环和认知功能的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2021
-
负责人:侯清华
-
依托单位:
鸦胆子素D靶向Cathepsin B诱导斜纹夜蛾幼虫中肠细胞凋亡的分子机制
-
批准号:32102225
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:毛根林
-
依托单位:
Cathepsin B/NLRP3炎症小体/IL-18信号通路在白塞病葡萄膜炎中的作用及机制研究
-
批准号:82000881
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:秦伟伟
-
依托单位:
Cathepsin B -NLRP3炎性小体通路在脑梗死后脑水肿发生中的作用以及机制研究
-
批准号:81974208
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:张世洪
-
依托单位: